The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Explore opportunities to influence, connect and save with the BIA.

Influence policymakers

 Influence

policymakers, ensuring your voice is heard on matters that are critical to the success of your organisation

Connect at BIA events

Connect

with the UK ecosystem through industry-leading events, expert committees and overseas missions

Save

Save

money with the BIA Business Solutions purchasing programme, helping your business grow cost-effectively


Biotech and life sciences news and insights

Press Releases

UK biotech investment increases amidst progress in City of London to unlock new capital

The second quarter of 2023 has seen steady growth in financing activity for the UK’s life sciences sector, as revealed by new data released by the BioIndustry Association (BIA) and Clarivate. The positive news comes soon after industry figures welcomed recent announcements to unlock new sources of capital in the City of London.

BIA is first occupier at Victoria House, London’s life sciences hub

Oxford and Pioneer Group launch plans for central London's largest office-to-life sciences conversion project, securing first lease with BIA.

BIA joins UK Health Data Research Alliance

The BioIndustry Association (BIA) joins the UK Health Data Research Alliance as a member, alongside UK national data custodians, NHS foundation trusts and research institutes to help develop best practice around the ethical use of health data. 

Pensions industry commitment to unlock investment welcomed by biotech leaders

Life science leaders applaud new initiatives to unlock pension fund assets for investment in the sector.

 

Member News

Stablepharma secures Innovate UK grant, bridge funding round to launch

This joint Innovate UK grant will advance the clinical development of Stablepharma’s lead candidate, SPVX02, a fridge-free vaccine for the prevention of Tetanus and Diphtheria, validating its safety and efficacy through first-in-human clinical trials.

Broken String Biosciences closes $15 million Series A funding round

Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design,  has closed a $15 million Series A investment round.

CPI launches RNA Centre of Excellence

UK's first RNA therapeutic innovation center opens in Darlington, driving cutting-edge vaccine and therapeutic development.

UK rare disease research landscape mapped for first time

A detailed view of rare disease research in the UK has been captured for the first time in a new report published today. It reveals over £1.1 billion has been invested by Government and charities over a five-year-period.

 

Blogs and spotlights

Women In Biotech Mentoring Programme: Mentee experience – Alex Gajdosova

In this interview, Alex Gajdosova, an Investment Analyst at 4BIO Capital reflects on her inspiring career journey and her decision to participate in the BIA’s Women In Biotech Mentoring Programme as a mentee.

CEO Update - 25 September 2023

The government is introducing legislation to reverse the reinstatement of the 1.5% stamp tax charge on issues and certain transfer of shares to depositary receipts issuers and clearance services – so as, broadly, to preserve the position as before the Retained EU Law (Revocation and Reform) Act was passed.

Women In Biotech Mentoring Programme: mentee experience - Hilary Birrell

In this interview, we delve into the remarkable career journey of Hilary Birrell, a seasoned biochemist with 35 years of experience in clinical trial operations. She shares her motivation for becoming a mentee in the Women In Biotech Mentoring Programme and the invaluable insights gained from her mentor.

CEO Update - 18 September 2023

It was an honour to represent our sector at the first-ever meeting of the UK Biosecurity Leadership Council, chaired by Science Minister George Freeman MP. Looking around the table, it was clear to see that the UK’s strategic advantage in the responsible use of engineering biology is that we have a diverse and world-leading set of capabilities from pioneering science to regulation and thought leadership – and that we are small enough, and networked enough as a nation to get together in a room to set agendas and work plans at pace and scale that can be globally impactful.

 

Latest resources

Here's a selection of featured BIA resources. Explore our Resources Hub  

BIA position on WHO pandemic accord

The UK Government is currently involved in the negotiation of an international treaty on pandemic preparedness and response at the World Health Organization (WHO). The BIA has submitted a position statement to Government.

 

Join us at the next BIA event!

Web listing image reg conference.png

The Future of UK Regulation Conference 2023

No.11 Cavendish Square, London
TechBio UK main image update.jpg

TechBio UK 2023

Kings Place, Kings Cross
Website event listing banner (002).png

20th Anniversary bioProcessUK Conference

Brighton

 

×

The Future of UK Regulation Conference 2023

Join us for an exciting and informative day and thought leadership on the future of regulation as a driver for innovation in the UK and beyond, bringing together MHRA senior leadership, key decision-makers, international stakeholders and the regulatory community across the life sciences ecosystem.

Register now

https://www.biaregulatoryconference.org/